Three adoption waves have been identified: Industrial (now), Consumer (next), and Medical (later).
The ASP will drop to ~$25,000 by 2035, driven by Chinese OEMs and reduced component costs.
China leads the race with over half of all active humanoid robot companies supported by government policies.
Dexterous hands and affordable actuators are key enablers for industrial, consumer, and medical-grade humanoids.
LBMs (Large Behaviour Models) allow robots to learn tasks with little coding, while LLMs enable intuitive communication. Coupled with lighter actuators, multi-hour batteries, and compact 200-TOPS processors, humanoids are now equipped for real-time perception and broad-skill operation.
“We are witnessing an inflection point,” says Yole’s Pierrick Boulay, “AI integration and component scalability are turning humanoids from complex prototypes into deployable machines with measurable ROI in logistics, manufacturing, and beyond.”
The global humanoid robot market will reach $6 billion in 2030 and soar to $51 billion in 2035, with ~55% CAGR. Shipments will rise to ~136 thousand in 2030, and more than 2 million by 2035.
The BOM is dominated by mechanical systems, dexterous hands, actuators, servomotors, and controllers, while silicon accounts for a smaller share, decreasing from ~8% in 2025 to ~5% in 2035 as compute and sensing components benefit from scale and integration.
Industrial (now): early rollouts target intralogistics and light assembly in existing plants and warehouses. The ROI stems from ergonomic relief and labor shortages, not one-for-one workstation replacement.
Examples include Apptronik’s Apollo at Mercedes-Benz and Agility’s Digit for bulk handling.
Consumer (next): price reduction led by Chinese OEMs such as Unitree enables educational and developer experimentation.
Medical (later): regulation and liability slow progress, but China’s State Council is promoting humanoids for elder care, rehabilitation, and hospital logistics, paving the way to bedside applications.
Humanoid robot ASP is projected to fall from $75,000 in 2025 to $25,000 in 2035.
Yole analysts estimate a 2025 BOM of US$32,000, with pricing shaped by market segmentation.
“The focus is shifting from motion to manipulation,” adds Boulay, “once dexterous hands enable robust interaction with tools and environments, cost reduction will open the doors to consumer adoption, followed by regulatory advances that unlock medical markets.”
More than 60 active humanoid companies have been identified globally with China having over 50% of them.
Since 2017, cumulative funding has reached $9.8 billion (as of October 2025), led by UBTECH and Figure AI, which together raised $4.3 billion.
Unitree leads in expected 2025 shipments (37% market share), followed by Tesla and AgiBot.
China’s MIIT is implementing a 2023–2025 plan to secure a complete humanoid innovation ecosystem, from core components to system integration, strengthening domestic production and supply chains.
“Humanoid robots are moving beyond research labs to become part of our daily lives, assisting in factories, homes, and even healthcare environments,” says Yole’s Claire Troadec, “we see this evolution generating a profound impact on the semiconductor industry, driving innovation across compute, sensing, and power technologies.”
See also: Humanoid Robot becomes CMO
